Implementation of PrEP to HIV in Brazilian Transgender Women
NCT03220152
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
HIV, Prevention
Interventions
DRUG:
emtricitabine / tenofovir 200/300 mg
Sponsor
Oswaldo Cruz Foundation